Natural killer cell-mediated lysis of autologous cells modified by gene therapy

Journal of Experimental Medicine

Volumn 189, Issue 12, 1999, Pages 1855-1862

  Liberatore, Concetta ^a   Capanni, Marusca ^a   Albi, Nicola ^a   Volpi, Isabella ^a   Urbani, Elena ^a   Ruggeri, Loredana ^a   Mencarelli, Amedea ^a   Grignani, Francesco ^a   Velardi, Andrea ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Gene therapy; Killer cell inhibitory receptor; Natural killer cells; Peptides; Retroviral vectors

Indexed keywords

HLA ANTIGEN; VIRUS VECTOR;

ARTICLE; AUTOTRANSPLANTATION; CONTROLLED STUDY; CYTOLYSIS; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; NATURAL KILLER CELL; PRIORITY JOURNAL; VIRUS INFECTION;

AMINO ACID SEQUENCE; CLONE CELLS; DRUG RESISTANCE, MICROBIAL; GENE THERAPY; GENETIC MARKERS; HLA-B ANTIGENS; HLA-B27 ANTIGEN; HUMANS; KANAMYCIN KINASE; KILLER CELLS, NATURAL; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE FRAGMENTS; RECEPTORS, IMMUNOLOGIC; RETROVIRIDAE; T-LYMPHOCYTES;

EID: 0033591740     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.12.1855     Document Type: Article

References (36)

1. Moretta, A. 1997. Molecular mechanisms in cell-mediated cytotoxicity. Cell. 90:13-18.
2. Lanier, L.L. 1997. Natural killer cells: from no receptors to too many. Immunity. 6:371-378.
3. Braud, V.M., D.S. Allan, C.A. O'Callaghan, K. Soderstrom, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:795-799.
4. Wagtmann, N., R. Biassoni, C. Cantoni, S. Verdiani, M. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, and E.O. Long. 1995. Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra-and intracellular domains. Immunity. 2:439-449.
5. Colonna, M., and J. Samaridis. 1995. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 268:405-408.
6. D'Andrea, A., C. Chang, K. Franz-Bacon, T. McClanahan, J.H. Phillips, and L.L. Lanier. 1995. Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypes. J. Immunol. 155:2306-2310.
7. Pende, D., R. Biassoni, C. Cantoni, S. Verdiani, M. Falco, C. Di Donato, L. Accame, C. Bottino, A. Moretta, and L. Moretta. 1996. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J. Exp. Med. 184:505-518.
8. Malnati, M.S., M. Peruzzi, K.C. Parker, W.E. Biddison, E. Ciccone, A. Moretta, and E.O. Long. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science. 267:1016-1018.
9. Peruzzi, M., N. Wagtmann, and E.O. Long. 1996. A p70 killer inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 184:1585-1590.
10. Peruzzi, M., K.C. Parker, E.O. Long, and M. Malnati. 1996. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J. Immunol. 157:3350-3356.
11. Rajagopalan, S., and E.O. Long. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185:1523-1528.
12. Zappacosta, F., F. Borrego, A.G. Brooks, K.C. Parker, and J.E. Coligan. 1997. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc. Natl. Acad. Sci. USA. 94:6313-6318.
13. Mandelboim, O., S.B. Wilson, M. Valés-Gòmez, H.T. Reyburn, and J.L. Strominger. 1997. Self and viral peptides can initiate lysis by autologous natural killer cells. Proc. Natl. Acad. Sci. USA. 94:4604-4609.
14. Kaufman, D.S., R.A. Schoon, and P.L. Liebson. 1992. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. Proc. Natl. Acad. Sci. USA. 89:8337-8341.
15. Miller, A.D. 1992. Human gene therapy comes of age. Nature. 357:455-460.
16. Verma, I.M., and N. Somia. 1997. Gene therapy - promises, problems and prospects. Nature. 389:239-242.
17. Tripathy, S.K., H.B. Black, E. Goldwasser, and J.M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550.
18. Yang, Y., F.A. Nunes, K. Berencsi, E.E. Furth, E. Gonczol, and J.M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA. 91:4407-4411.
19. Yang, Y., Z. Xiang, H.C. Ertl, and J.M. Wilson. 1995. Up-regulation of class I major histocompatibility complex antigens by interferon γ is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA. 92:7257-7261.
20. Dai, Y., E.M. Schwarz, D. Gu, W. Zhang, N. Sarvetnick, and I.M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA. 92:1401-1405.
21. Yang, Y., J. Ertl, and J.M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity. 1:433-442.
22. Yang, Y., Q. Li, H.C. Ertl, and J.M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
23. Riddell, S.R., M. Elliott, D.A. Lewinsohn, M.J. Gilbert, L. Wilson, S.A. Manley, S.D. Lupton, R.W. Overell, T.C. Reynolds, L. Corey, et al. 1996. T-cell mediated rejection of gene modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2:216-223.
24. Bonini, C., G. Ferrari, S. Verzelletti, P. Servida, E. Zappone, L. Ruggieri, M. Ponzoni, S. Rossini, F. Mavilio, C. Traversari, et al. 1996. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 276:1719-1724.
25. Rosenberg, S.A., P. Aebersold, K. Cornetta, A. Kasid, R.A. Morgan, R. Moen, E.M. Karson, M.T. Lotze, J.C. Yang, S.L. Topalian, et al. 1990. Gene transfer into humans: immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323:570-578.
26. Bordignon, C., L.D. Notarangelo, N. Nobili, G. Ferrari, G. Casorati, P. Panina, E. Mazzolari, D. Maggioni, C. Rossi, P. Servida, et al. 1995. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science. 270:470-475.
27. Blaese, R.M., K.W. Culver, A.D. Miller, C.S. Carter, T. Fleisher, M. Clerici, G. Shearer, L. Chang, Y. Chiang, P. Tolstoshev, et al. 1995. T-lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science. 270: 475-480.
28. + cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood. 89:4040-4046.
29. Vitale, M., S. Sivori, D. Pende, R. Agugliaro, C. Di Donato, A. Amoroso, M. Malnati, C. Bottino, L. Moretta, and A. Moretta. 1996. Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc. Natl. Acad. Sci. USA. 93:1453-1457.
30. + T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation. Blood. 87:3993-4000.
31. Biassoni, R., M. Falco, A. Cambiaggi, P. Costa, S. Verdiani, D. Pende, R. Conte, C. Di Donato, P. Parham, and L. Moretta. 1995. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J. Exp. Med. 182:605-609.
32. Miller, A.D., and G.J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. Biotechniques. 7:980-982.
33. Kinsella, T.M., and G.P. Nolan. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1405-1413.
34. Bregni, M., M. Magni, S. Siena, M. Di Nicola, G. Bonadonna, and A.M. Gianni. 1992. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood. 80:1418-1422.
35. Salemi, S., A.P. Caporossi, L. Boffa, M.G. Longobardi, and V. Barnaba. 1995. HIVgp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J. Exp. Med. 181:2253-2257.
36. Rammensee, H.G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:178-228.